Last updated: February 25, 2025
Sponsor: University of Minnesota
Overall Status: Active - Recruiting
Phase
N/A
Condition
Dupuytren's Disease
Treatment
Evaluation of Dupuytren's Disease Treatment
Clinical Study ID
NCT04122313
ORTHOSURG-2018-26681
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Diagnoses of Dupuytren's disease
English-speaking
Exclusion
Exclusion Criteria:
- Patients with Dupuytren's disease who are not currently seeking treatment
Study Design
Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Evaluation of Dupuytren's Disease Treatment
Phase:
Study Start date:
May 31, 2019
Estimated Completion Date:
March 01, 2026
Study Description
Connect with a study center
University of Minnesota
Minneapolis, Minnesota 55455
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.